Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization.
Adv Ther
; 38(2): 1212-1226, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-996463
ABSTRACT
INTRODUCTION:
Coronavirus disease 2019 (COVID-19) has imposed a considerable burden on the United States (US) health system, with particular concern over healthcare capacity constraints.METHODS:
We modeled the impact of public and private sector contributions to developing diagnostic testing and treatments on COVID-19-related healthcare resource use.RESULTS:
We estimated that public sector contributions led to at least 30% reductions in COVID-19-related healthcare resource utilization. Private sector contributions to expanded diagnostic testing and treatments led to further reductions in mortality (- 44%), intensive care unit (ICU) and non-ICU hospital beds (- 30% and - 28%, respectively), and ventilator use (- 29%). The combination of lower diagnostic test sensitivity and proportions of patients self-isolating may exacerbate case numbers, and policies that encourage self-isolating should be considered.CONCLUSION:
While mechanisms exist to facilitate research, development, and patient access to diagnostic testing, future policies should focus on ensuring equitable patient access to both diagnostic testing and treatments that, in turn, will alleviate COVID-19-related resource constraints.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Public Sector
/
Private Sector
/
COVID-19
/
Health Resources
/
Health Services Needs and Demand
Type of study:
Diagnostic study
/
Experimental Studies
/
Prognostic study
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Adv Ther
Journal subject:
Therapeutics
Year:
2021
Document Type:
Article
Affiliation country:
S12325-020-01597-3
Similar
MEDLINE
...
LILACS
LIS